Novavax Says Entered Supply Chain Agreement With The Serum Institute Of India; Says Agreement For Supply To Co Of Vaccine Product Derived From A Coformulation Of BV2373 Antigen, Including Variants Thereof

by | Nov 1, 2021 | Uncategorized | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.